LOADING
Comparing Johnson & Johnson (JNJ) and Comcast Corporation (CMCSA) across the Health Care and Communication Services sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | JNJ | CMCSA |
|---|---|---|
| Price | $257.20 | $24.51 |
| Change Today | +0.89% | -1.70% |
| Market Cap | $613.1B | $88.5B |
| P/E Ratio | 29.6 | 7.9 |
| Forward P/E | 22.0 | 6.9 |
| PEG Ratio | 4.23 | 2.39 |
| EPS | $8.61 | $3.17 |
| Revenue Growth (YoY) | 6.6% | -1.2% |
| Profit Margin | 21.5% | 9.0% |
| Return on Equity | 25.7% | 11.5% |
| Dividend Yield | 2.04% | 5.37% |
| Beta | 0.23 | 0.65 |
| 52-Week High | $274.90 | $32.05 |
| 52-Week Low | $165.53 | $21.28 |
| Volume | 9K | 74K |
Johnson & Johnson is the larger company by market capitalization. Comcast Corporation trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Comcast Corporation offers a higher dividend yield for income investors. Johnson & Johnson has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.